David Risinger

Stock Analyst at Leerink Partners

(3.58)
# 859
Out of 5,041 analysts
172
Total ratings
65.93%
Success rate
14.58%
Average return

Stocks Rated by David Risinger

Halozyme Therapeutics
Oct 14, 2025
Upgrades: Market Perform
Price Target: $70
Current: $66.89
Upside: +4.66%
Vertex Pharmaceuticals
Sep 25, 2025
Upgrades: Outperform
Price Target: $458$456
Current: $422.63
Upside: +7.90%
Metsera
Sep 24, 2025
Downgrades: Market Perform
Price Target: $77$57
Current: $52.63
Upside: +8.30%
Roivant Sciences
Sep 18, 2025
Maintains: Outperform
Price Target: $18$22
Current: $18.12
Upside: +21.41%
Johnson & Johnson
May 13, 2025
Downgrades: Market Perform
Price Target: $169$153
Current: $192.47
Upside: -20.51%
Regeneron Pharmaceuticals
Feb 5, 2025
Upgrades: Outperform
Price Target: $762$834
Current: $575.69
Upside: +44.87%
AbbVie
Nov 22, 2024
Upgrades: Outperform
Price Target: $206
Current: $228.25
Upside: -9.75%
Bristol-Myers Squibb Company
Nov 12, 2024
Upgrades: Outperform
Price Target: $55$73
Current: $43.83
Upside: +66.55%
Tectonic Therapeutic
Nov 11, 2024
Maintains: Outperform
Price Target: $49$69
Current: $17.39
Upside: +296.78%
Tenax Therapeutics
Oct 24, 2024
Initiates: Outperform
Price Target: $16
Current: $7.33
Upside: +118.28%
Initiates: Outperform
Price Target: $44
Current: $27.13
Upside: +62.18%
Maintains: Outperform
Price Target: $106$153
Current: $41.60
Upside: +267.79%
Downgrades: Market Perform
Price Target: $15$10
Current: $14.14
Upside: -29.28%
Initiates: Outperform
Price Target: $47
Current: $34.00
Upside: +38.24%
Upgrades: Outperform
Price Target: $267$318
Current: $292.89
Upside: +8.57%
Maintains: Outperform
Price Target: $6$11
Current: $24.14
Upside: -54.43%
Maintains: Outperform
Price Target: $410$458
Current: $821.04
Upside: -44.22%
Maintains: Market Perform
Price Target: $81$91
Current: $120.74
Upside: -24.63%
Maintains: Market Perform
Price Target: $49$48
Current: $24.67
Upside: +94.57%
Maintains: Equal-Weight
Price Target: $35$37
Current: $9.05
Upside: +308.84%
Maintains: Equal-Weight
Price Target: $162$176
Current: $138.18
Upside: +27.37%
Maintains: Equal-Weight
Price Target: $18$16
Current: $10.31
Upside: +55.19%
Maintains: Equal-Weight
Price Target: $53$45
Current: $21.50
Upside: +109.30%
Maintains: Equal-Weight
Price Target: $22$35
Current: $6.38
Upside: +448.59%
Maintains: Overweight
Price Target: $31$41
Current: $21.77
Upside: +88.33%
Maintains: Equal-Weight
Price Target: $167$174
Current: $146.39
Upside: +18.86%
Initiates: Equal-Weight
Price Target: $51
Current: $36.85
Upside: +38.40%
Maintains: Underweight
Price Target: $13$8
Current: $19.02
Upside: -57.94%
Maintains: Overweight
Price Target: $97$89
Current: $87.18
Upside: +2.09%
Maintains: Equal-Weight
Price Target: $5$3
Current: $10.42
Upside: -71.21%
Maintains: Equal-Weight
Price Target: $20$16
Current: $30.04
Upside: -46.74%